Do analysts rate ZJYL or NNOX?

Nano-X Imaging has a consensus target price of $4.33, indicating a potential upside of 403.93%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nano-X Imaging 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has preferable valuation and earnings, ZJYL or NNOX?

Jin Medical International has higher revenue and earnings than Nano-X Imaging. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 11.52 $1.19M N/A N/A Nano-X Imaging $13.02M 5.19 -$75.02M -$1.58 N/A

Does the media prefer OBIO or NNOX?

In the previous week, Nano-X Imaging had 2 more articles in the media than Orchestra BioMed. MarketBeat recorded 4 mentions for Nano-X Imaging and 2 mentions for Orchestra BioMed. Orchestra BioMed's average media sentiment score of 0.47 beat Nano-X Imaging's score of -0.24 indicating that Orchestra BioMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orchestra BioMed 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is STIM or NNOX more profitable?

Neuronetics has a net margin of -19.62% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -19.62% -125.11% -22.15% Nano-X Imaging -716.44% -70.96% -62.26%

Does the media prefer STIM or NNOX?

In the previous week, Neuronetics and Neuronetics both had 4 articles in the media. Neuronetics' average media sentiment score of 1.20 beat Nano-X Imaging's score of -0.24 indicating that Neuronetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer RCEL or NNOX?

In the previous week, Avita Medical had 4 more articles in the media than Nano-X Imaging. MarketBeat recorded 8 mentions for Avita Medical and 4 mentions for Nano-X Imaging. Avita Medical's average media sentiment score of 0.54 beat Nano-X Imaging's score of -0.24 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PROF or NNOX?

In the previous week, Nano-X Imaging had 2 more articles in the media than Profound Medical. MarketBeat recorded 4 mentions for Nano-X Imaging and 2 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat Nano-X Imaging's score of -0.24 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Nano-X Imaging (NNOX) Competitors

$0.86 -0.03 (-2.84%)

As of 08/21/2026 04:00 PM Eastern

Compare

NNOX vs. ZJYL, OBIO, STIM, RCEL, and PROF

Should you buy Nano-X Imaging stock or one of its competitors? Nano-X Imaging's main competitors and comparable companies include Jin Medical International (ZJYL), Orchestra BioMed (OBIO), Neuronetics (STIM), Avita Medical (RCEL), and Profound Medical (PROF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Nano-X Imaging compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

21.5% of Nano-X Imaging shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Nano-X Imaging had 4 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Nano-X Imaging and 0 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 beat Nano-X Imaging's score of -0.24 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Overall Sentiment
Jin Medical International	Neutral
Nano-X Imaging	Neutral

Nano-X Imaging has a consensus target price of $4.33, indicating a potential upside of 403.93%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Jin Medical International has a beta of 7.34, suggesting that its stock price is 634% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to Nano-X Imaging's net margin of -716.44%. Jin Medical International's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Nano-X Imaging	-716.44%	-70.96%	-62.26%

Jin Medical International has higher revenue and earnings than Nano-X Imaging.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	11.52	$1.19M	N/A	N/A
Nano-X Imaging	$13.02M	5.19	-$75.02M	-$1.58	N/A

Summary

Jin Medical International beats Nano-X Imaging on 8 of the 15 factors compared between the two stocks.

How does Nano-X Imaging compare to Orchestra BioMed?

Orchestra BioMed (NASDAQ:OBIO) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

53.2% of Orchestra BioMed shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 7.5% of Orchestra BioMed shares are owned by insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Nano-X Imaging had 2 more articles in the media than Orchestra BioMed. MarketBeat recorded 4 mentions for Nano-X Imaging and 2 mentions for Orchestra BioMed. Orchestra BioMed's average media sentiment score of 0.47 beat Nano-X Imaging's score of -0.24 indicating that Orchestra BioMed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orchestra BioMed	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Orchestra BioMed has a net margin of -184.60% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Orchestra BioMed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orchestra BioMed	-184.60%	-149.61%	-54.15%
Nano-X Imaging	-716.44%	-70.96%	-62.26%

Orchestra BioMed has higher revenue and earnings than Nano-X Imaging. Orchestra BioMed is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orchestra BioMed	$33.48M	9.62	-$52.70M	-$0.85	N/A
Nano-X Imaging	$13.02M	5.19	-$75.02M	-$1.58	N/A

Orchestra BioMed has a beta of 0.5, meaning that its stock price is 50% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

Orchestra BioMed presently has a consensus price target of $13.00, suggesting a potential upside of 142.54%. Nano-X Imaging has a consensus price target of $4.33, suggesting a potential upside of 403.93%. Given Nano-X Imaging's higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Orchestra BioMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orchestra BioMed	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Orchestra BioMed beats Nano-X Imaging on 10 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Neuronetics has a net margin of -19.62% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-19.62%	-125.11%	-22.15%
Nano-X Imaging	-716.44%	-70.96%	-62.26%

Neuronetics has higher revenue and earnings than Nano-X Imaging. Neuronetics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	1.53	-$39M	-$0.44	N/A
Nano-X Imaging	$13.02M	5.19	-$75.02M	-$1.58	N/A

Neuronetics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

In the previous week, Neuronetics and Neuronetics both had 4 articles in the media. Neuronetics' average media sentiment score of 1.20 beat Nano-X Imaging's score of -0.24 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Neuronetics currently has a consensus target price of $4.50, suggesting a potential upside of 50.00%. Nano-X Imaging has a consensus target price of $4.33, suggesting a potential upside of 403.93%. Given Nano-X Imaging's higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Neuronetics beats Nano-X Imaging on 9 of the 15 factors compared between the two stocks.

How does Nano-X Imaging compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

In the previous week, Avita Medical had 4 more articles in the media than Nano-X Imaging. MarketBeat recorded 8 mentions for Avita Medical and 4 mentions for Nano-X Imaging. Avita Medical's average media sentiment score of 0.54 beat Nano-X Imaging's score of -0.24 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avita Medical has a net margin of -56.96% compared to Nano-X Imaging's net margin of -716.44%. Avita Medical's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
Nano-X Imaging	-716.44%	-70.96%	-62.26%

Avita Medical presently has a consensus price target of $10.20, suggesting a potential upside of 1.39%. Nano-X Imaging has a consensus price target of $4.33, suggesting a potential upside of 403.93%. Given Nano-X Imaging's higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Avita Medical has higher revenue and earnings than Nano-X Imaging. Avita Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	4.32	-$48.59M	-$1.44	N/A
Nano-X Imaging	$13.02M	5.19	-$75.02M	-$1.58	N/A

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 2.2% of Avita Medical shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Avita Medical has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Summary

Avita Medical beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Profound Medical?

Profound Medical (NASDAQ:PROF) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

In the previous week, Nano-X Imaging had 2 more articles in the media than Profound Medical. MarketBeat recorded 4 mentions for Nano-X Imaging and 2 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat Nano-X Imaging's score of -0.24 indicating that Profound Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profound Medical has a net margin of -171.57% compared to Nano-X Imaging's net margin of -716.44%. Profound Medical's return on equity of -63.03% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-171.57%	-63.03%	-51.24%
Nano-X Imaging	-716.44%	-70.96%	-62.26%

Profound Medical has higher revenue and earnings than Nano-X Imaging. Profound Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	15.33	-$42.57M	-$0.98	N/A
Nano-X Imaging	$13.02M	5.19	-$75.02M	-$1.58	N/A

Profound Medical presently has a consensus price target of $11.50, suggesting a potential upside of 69.37%. Nano-X Imaging has a consensus price target of $4.33, suggesting a potential upside of 403.93%. Given Nano-X Imaging's higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Profound Medical has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Summary

Profound Medical beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NNOX vs. The Competition

Export

Metric	Nano-X Imaging	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$67.58M	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.75%	2.53%	11.08%
P/E Ratio	-0.54	26.67	272.60	24.24
Price / Sales	5.19	45.38	618.96	99.81
Price / Cash	N/A	33.24	78.62	53.99
Price / Book	0.43	6.23	13.05	6.20
Net Income	-$75.02M	$150.07M	$3.47B	$348.59M
7 Day Performance	-13.81%	0.69%	2.09%	0.08%
1 Month Performance	-11.70%	8.91%	6.64%	3.88%
1 Year Performance	-78.82%	8.07%	25.02%	16.98%

Nano-X Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NNOX Nano-X Imaging	4.0678 of 5 stars	$0.86 -2.8%	$4.33 +403.9%	-78.8%	$67.58M	$13.02M	N/A	190	Upcoming Earnings
ZJYL Jin Medical International	N/A	$3.46 +2.4%	N/A	-79.0%	$265.10M	$20.69M	N/A	245	Gap Up
OBIO Orchestra BioMed	3.3795 of 5 stars	$4.72 +7.0%	$13.00 +175.4%	+110.2%	$265.06M	$33.48M	N/A	4
STIM Neuronetics	3.936 of 5 stars	$3.27 -0.9%	$4.50 +37.6%	-11.8%	$251.45M	$149.16M	N/A	180	Positive News
RCEL Avita Medical	1.7591 of 5 stars	$7.90 +0.6%	$8.25 +4.4%	+106.1%	$241.60M	$71.61M	N/A	130	Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano-X Imaging (NNOX) Competitors

NNOX vs. ZJYL, OBIO, STIM, RCEL, and PROF

How does Nano-X Imaging compare to Jin Medical International?

Summary

How does Nano-X Imaging compare to Orchestra BioMed?

Summary

How does Nano-X Imaging compare to Neuronetics?

Summary

How does Nano-X Imaging compare to Avita Medical?

Summary

How does Nano-X Imaging compare to Profound Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano-X Imaging (NNOX) Competitors

NNOX vs. ZJYL, OBIO, STIM, RCEL, and PROF

How does Nano-X Imaging compare to Jin Medical International?

Do insiders and institutionals have more ownership in ZJYL or NNOX?

Does the media prefer ZJYL or NNOX?

Do analysts rate ZJYL or NNOX?

Which has more risk and volatility, ZJYL or NNOX?

Is ZJYL or NNOX more profitable?

Which has preferable valuation and earnings, ZJYL or NNOX?

Summary

How does Nano-X Imaging compare to Orchestra BioMed?

Do insiders & institutionals have more ownership in OBIO or NNOX?

Does the media prefer OBIO or NNOX?

Is OBIO or NNOX more profitable?

Which has stronger valuation & earnings, OBIO or NNOX?

Which has more risk & volatility, OBIO or NNOX?

Do analysts rate OBIO or NNOX?

Summary

How does Nano-X Imaging compare to Neuronetics?

Is STIM or NNOX more profitable?

Which has better earnings and valuation, STIM or NNOX?

Which has more volatility & risk, STIM or NNOX?

Does the media prefer STIM or NNOX?

Do institutionals and insiders have more ownership in STIM or NNOX?

Do analysts rate STIM or NNOX?

Summary

How does Nano-X Imaging compare to Avita Medical?

Does the media prefer RCEL or NNOX?

Is RCEL or NNOX more profitable?

Do analysts rate RCEL or NNOX?

Which has higher valuation and earnings, RCEL or NNOX?

Do institutionals & insiders have more ownership in RCEL or NNOX?

Which has more risk and volatility, RCEL or NNOX?

Summary

How does Nano-X Imaging compare to Profound Medical?

Does the media prefer PROF or NNOX?

Do insiders and institutionals believe in PROF or NNOX?

Is PROF or NNOX more profitable?

Which has preferable earnings & valuation, PROF or NNOX?

Do analysts prefer PROF or NNOX?

Which has more risk and volatility, PROF or NNOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools